Chahrour, M. & Zoghbi, H. Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422–437 (2007).

Article  PubMed  CAS  Google Scholar 

Ip, J. P. K., Mellios, N. & Sur, M. Rett syndrome: insights into genetic, molecular and circuit mechanisms. Nat. Rev. Neurosci. 19, 368–382 (2018).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Leonard, H., Cobb, S. & Downs, J. Clinical and biological progress over 50 years in Rett syndrome. Nat. Rev. Neurol. 13, 37–51 (2017).

Article  PubMed  CAS  Google Scholar 

Lyst, M. J. & Bird, A. Rett syndrome: a complex disorder with simple roots. Nat. Rev. Genet. 16, 261–275 (2015).

Article  PubMed  CAS  Google Scholar 

Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185–188 (1999).

Article  PubMed  CAS  Google Scholar 

Trappe, R. et al. MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am. J. Hum. Genet. 68, 1093–1101 (2001).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Guy, J., Hendrich, B., Holmes, M., Martin, J. E. & Bird, A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27, 322–326 (2001).

Article  PubMed  CAS  Google Scholar 

Chen, R. Z., Akbarian, S., Tudor, M. & Jaenisch, R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 27, 327–331 (2001).

Article  PubMed  CAS  Google Scholar 

Vashi, N. & Justice, M. J. Treating Rett syndrome: from mouse models to human therapies. Mamm. Genome 30, 90–110 (2019).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Giacometti, E., Luikenhuis, S., Beard, C. & Jaenisch, R. Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc. Natl Acad. Sci. USA 104, 1931–1936 (2007).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Guy, J., Gan, J., Selfridge, J., Cobb, S. & Bird, A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143–1147 (2007).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Van Esch, H. MECP2 duplication syndrome. Mol. Syndromol. 2, 128–136 (2012).

Article  PubMed  Google Scholar 

Anguera, M. C. et al. Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell 11, 75–90 (2012).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sharifi, O. & Yasui, D. H. The molecular functions of MeCP2 in Rett syndrome pathology. Front. Genet. 12, 624290 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tillotson, R. & Bird, A. The molecular basis of MeCP2 function in the brain. J. Mol. Biol. 432, 1602–1623 (2020).

Article  PubMed  CAS  Google Scholar 

Horvath, P. M. & Monteggia, L. M. MeCP2 as an activator of gene expression. Trends Neurosci. 41, 72–74 (2018).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Meehan, R. R., Lewis, J. D. & Bird, A. P. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res. 20, 5085–5092 (1992).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lewis, J. D. et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905–914 (1992).

Article  PubMed  CAS  Google Scholar 

Free, A. et al. DNA recognition by the methyl-CpG binding domain of MeCP2. J. Biol. Chem. 276, 3353–3360 (2001).

Article  PubMed  CAS  Google Scholar 

Skene, P. J. et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 37, 457–468 (2010). This study shows the global distribution of MECP2 and its correlation with mCpG density across the neuronal genome.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Guo, J. U. et al. Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat. Neurosci. 17, 215–222 (2014).

Article  PubMed  CAS  Google Scholar 

Xie, W. et al. Base-resolution analyses of sequence and parent-of-origin dependent DNA methylation in the mouse genome. Cell 148, 816–831 (2012).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lister, R. et al. Global epigenomic reconfiguration during mammalian brain development. Science 341, 1237905 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Chen, L. et al. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome. Proc. Natl Acad. Sci. USA 112, 5509–5514 (2015).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gabel, H. W. et al. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome. Nature 522, 89–93 (2015). The study shows association of gene length and non-CG DNA methylation with gene regulation by MECP2.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lagger, S. et al. MeCP2 recognizes cytosine methylated tri-nucleotide and di-nucleotide sequences to tune transcription in the mammalian brain. PLoS Genet. 13, e1006793 (2017). This study shows a significant correlation of MECP2 binding to mCAC with transcriptional misregulation in mouse models of Rett syndrome.

Article  PubMed  PubMed Central  Google Scholar 

Boxer, L. D. et al. MeCP2 represses the rate of transcriptional initiation of highly methylated long genes. Mol. Cell 77, 294–309.e299 (2020). This study describes a model of MECP2 acting at transcription start sites of highly methylated long genes to attenuate transcriptional initiation.

Article  PubMed  CAS  Google Scholar 

Kinde, B., Wu, D. Y., Greenberg, M. E. & Gabel, H. W. DNA methylation in the gene body influences MeCP2-mediated gene repression. Proc. Natl Acad. Sci. USA 113, 15114–15119 (2016).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Raman, A. T. et al. Apparent bias toward long gene misregulation in MeCP2 syndromes disappears after controlling for baseline variations. Nat. Commun. 9, 3225 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Clemens, A. W. et al. MeCP2 represses enhancers through chromosome topology-associated DNA methylation. Mol. Cell 77, 279–293.e278 (2020). Repressor model for MECP2 with binding to mCA domains to suppress intragenic enhancer activity and gene expression.

Article  PubMed  CAS